AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A budget should evolve with your life. Update your budget when your income, expenses, or priorities change to stay on track.
17,567 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Meta and Amazon are at the forefront of a trillion-dollar Big Tech capex surge, led by AI infrastructure and data-cen...
Investors in YMAX face layered fees from a fund-of-funds structure. With a 1.33% expense ratio on top of underlying E...
June’s producer price index fell 0.3% from May as energy prices slid, signaling cooling inflation. Yet geopolitical t...
A trio of tech giants is sending a quiet, powerful message about AI infrastructure spending. SpaceX, Alphabet, and SK...
A retirement wave, not automation, is tightening the U.S. labor pool. This piece explains how aging workers impact So...
Archer Aviation sparked a strong intraday move after revealing Thunder, a hybrid VTOL platform developed with Anduril...
As 2026 kicks off, crypto markets show surprising resilience. Venezuela's evolving policy and remittance dynamics are...
A widening Epstein-related inquiry fuels renewed scrutiny of global power players. As whispers of the former Prince A...
A vast recall affects fried rice sold trader products distributed to Trader Joe's stores across the U.S. and in Canad...
A leading Substack economist warns that ghost gdp could erase friction in the economy, accelerating a white-collar re...
As Haverty prepares for its 2025 earnings release, investors seek clarity on margins, store performance, and forward ...